Complete architecture reference for the A3 insurance platform — file locations, data flow, conventions, microservice map, and fullstack patterns
日本語の概要は準備中です。原文の説明を表示しています。
Decompose and explain healthcare cost growth into contributing factors including utilization changes, unit price shifts, case mix evolution, and population changes. Use when analyzing PMPM cost trends, explaining cost variance to leadership, preparing actuarial summaries, or identifying cost reduction opportunities.
インストールする前に、エージェントに与えられる指示の中身を確認できます。
This skill breaks down total healthcare cost changes into their component drivers — utilization rate changes, unit cost (price) changes, case-mix/severity shifts, population composition changes, and benefit design effects. It applies actuarial decomposition methods, Kitagawa-Blinder-Oaxaca analysis, and service-category drill-downs to produce transparent, auditable explanations of cost trends.
| Input | Description | Format |
|---|---|---|
| Claims data | Allowed amounts, service dates, CPT/HCPCS, revenue codes, DRG | Claims detail |
| Enrollment data | Member months, plan type, LOB, age/sex | Enrollment file |
| Service categories | Inpatient, outpatient, professional, pharmacy, ancillary | Category mapping |
| Network data | In-network vs. OON, contracted rates, provider type | Network file |
| Benefit design | Copay/coinsurance structure, deductible levels, formulary tier | Plan design |
| Prior period data | Same data elements for comparison period(s) | Historical claims |
Convert all cost data to per-member-per-month (PMPM) for trend comparability:
Apply the fundamental cost identity:
Cost PMPM = Utilization Rate × Unit Cost × Case Mix Index
For each service category, separate:
Calculate the contribution of each component to total cost change using the decomposition:
ΔCost = ΔUtil × Price₀ × Mix₀ + Util₀ × ΔPrice × Mix₀ + Util₀ × Price₀ × ΔMix + interaction terms
Decompose each major service category into sub-categories:
Inpatient:
Outpatient:
Professional:
Pharmacy:
Isolate cost changes due to population composition shifts:
Categorize each driver by controllability:
| Category | Controllable? | Intervention Lever |
|---|---|---|
| Unit price increases | Partially | Network contracting, reference-based pricing |
| Utilization growth | Partially | UM programs, care management, prior auth |
| Case mix severity | Limited | Risk adjustment accuracy, documentation |
| Population aging | Not controllable | Adjust expectations and pricing |
| New technology/drugs | Limited | Formulary management, clinical pathways |
| Site-of-service shift | Yes | Benefit design, steering programs |
| Waste/low-value care | Yes | Choosing Wisely campaigns, clinical decision support |
Compare observed drivers against external references:
Synthesize findings into a structured explanation:
Example narrative structure:
"Total medical cost PMPM increased 7.2% ($485 → $520). This was driven by:
• Unit price increases: +3.8% (hospital rate escalators +4.2%, offset by Rx generic conversions)
• Utilization changes: +2.1% (ED visits +8%, offset by IP admits −3%)
• Case mix: +0.9% (higher acuity surgical cases, new specialty drug starts)
• Population mix: +0.4% (aging, risk score increase)
Of the 7.2% trend, approximately 3.5 points are addressable through site-of-service
steering, ED diversion programs, and specialty pharmacy management."
Cost Driver Report:
├── Executive Summary (total PMPM trend, top 3 drivers, actionable share)
├── PMPM Trend Summary (by service category, current vs. prior)
├── Decomposition Waterfall (price, utilization, mix contributions)
├── Service Category Deep Dives (IP, OP, Professional, Rx)
├── Population Mix Analysis (age/sex, risk score, enrollment changes)
├── Benchmark Comparison (observed vs. expected by driver)
├── Controllability Assessment (actionable vs. non-actionable drivers)
├── Cost Reduction Opportunity Inventory (estimated savings by lever)
└── Methodology and Data Notes (IBNR factors, normalization methods)
Present as a waterfall chart data structure:
| Component | Contribution | Running Total |
|---|---|---|
| Starting PMPM | $485.00 | $485.00 |
| + Price changes | +$18.43 | $503.43 |
| + Utilization changes | +$10.19 | $513.62 |
| + Case mix shift | +$4.37 | $517.99 |
| + Population mix | +$1.94 | $519.93 |
| + Interaction | +$0.07 | $520.00 |
| = Ending PMPM | $520.00 |
Example 1 — Annual Cost Trend for Commercial Plan Decompose a 9.1% PMPM increase for a 120,000-member commercial plan. Price contributed +4.2% (hospital contract escalators), utilization +2.8% (driven by 14% ED growth and specialty referral increases), pharmacy mix +1.6% (two new specialty drugs), population +0.5%. Identify $14M addressable through ED diversion ($4M), site-of-service steering ($6M), and specialty pharmacy step therapy ($4M).
Example 2 — MA Plan Cost Driver Analysis Explain why a 40,000-member MA plan's medical loss ratio increased from 84% to 87%. Decompose: inpatient cost +11% (3 high-cost transplant cases contributed 40% of IP increase), outpatient +6% (advanced imaging), pharmacy +9% (Part B drugs). After removing outlier cases, underlying trend is 5.8%, within actuarial expectations.
This skill processes aggregate financial and utilization data. When patient-level claims are used in decomposition, all processing must comply with HIPAA Privacy and Security Rules. Apply minimum necessary data access. Large-claim analyses that reference specific cases must be de-identified in reports per 45 CFR §164.514. Cost reports shared with brokers, consultants, or external actuaries require Business Associate Agreements. Never include member identifiers in cost trend outputs.
まだレビューはありません。使ってみた感想をお寄せください。
概要と使いどころ
Complete architecture reference for the A3 insurance platform — file locations, data flow, conventions, microservice map, and fullstack patterns
日本語の概要は準備中です。原文の説明を表示しています。
Drafts U.S. commercial real estate access and indemnity (right-of-entry) agreements for pre-closing due diligence. Covers license grants, non-invasive vs invasive testing gates, insurance/endorsement requirements, indemnity with discovery carve-outs, restoration and lien remedies, confidentiality, and anti-indemnity guardrails. Trigger: access agreement, right of entry, due diligence access, Phase I/II, invasive testing, pre-PSA site inspection.
日本語の概要は準備中です。原文の説明を表示しています。
当用户需要对意外险投保问卷进行专业、结构化的核保审查,提取职业类别、工作环境、作业内容、危险活动参与情况、交通出行习惯、特殊工作暴露及其他可能影响意外险承保判断的高风险信息,并生成适合意外险核保、补问流转和风险分层处理的结构化分析结果时使用本 skill。
日本語の概要は準備中です。原文の説明を表示しています。
Inspect, schema, and fill true AcroForm PDFs using sciClaw's pdf_form_inspect, pdf_form_schema, and pdf_form_fill tools. Use when: (1) checking whether a PDF is a real fillable AcroForm, (2) listing form field names, types, and choices, (3) filling a supported form from structured values, (4) preparing reviewable insurance, legal, administrative, or clinical form drafts, (5) reporting skipped fields or unused input keys after a fill. Do not use for scanned PDFs, OCR tasks, or XFA-only forms.
日本語の概要は準備中です。原文の説明を表示しています。
Guide actuarial analysis for insurance pricing. TRIGGERS - Use when user needs help with actuarial-analysis related tasks.
日本語の概要は準備中です。原文の説明を表示しています。
Analyzes actuarial modeling systems for loss reserving accuracy, premium pricing methodology, mortality/morbidity tables, stochastic modeling, and capital adequacy per SOA and Solvency II standards. USE THIS SKILL WHEN: - You need to review or audit actuarial models (reserving, pricing, capital) - Someone asks about loss triangle analysis or reserve adequacy - You are evaluating IBNR calculations, chain ladder methods, or Bornhuetter-Ferguson - A project involves insurance pricing, GLM rating models, or ratemaking - You need to assess Solvency II SCR calculations or RBC compliance - Someone mentions actuarial opinions, ASOP compliance, or SOA standards - You are reviewing stochastic models, ESG configurations, or DFA frameworks - A codebase uses actuarial libraries (chainladder, lifetables, ChainLadder R package) TRIGGER PHRASES: "actuarial", "loss reserving", "IBNR", "chain ladder", "premium pricing", "mortality table", "Solvency II", "capital adequacy", "ratemaking", "GLM pricing", "risk-based capital", "reserve analysis", "actuarial opinion"
日本語の概要は準備中です。原文の説明を表示しています。